I now have comprehensive data from multiple authoritative textbooks. Let me compile the complete answer.
Mechanical ventilation (MV) fundamentally reverses normal respiratory physiology: spontaneous breathing creates negative intrathoracic pressure; MV creates positive intrathoracic pressure. This reversal drives all cardiovascular effects.
Viva Point: "Why can initiating MV cause cardiovascular collapse?" Answer: PPV reduces venous return and CO; if the patient is already hypovolemic or vasodilated (e.g., sepsis), this reduction unmasks haemodynamic instability. Always pre-load the patient before intubation if possible.
VILI is additional lung damage caused by mechanical ventilation itself. Four mechanisms are classically described:
Viva Point: "Name the 4 mechanisms of VILI." Answer: Barotrauma (pressure), Volutrauma (volume), Atelectrauma (shear from cycling), Biotrauma (cytokine release). Collectively these are avoided by lung-protective ventilation: tidal volume 6 mL/kg PBW, plateau pressure <30 cmH₂O, adequate PEEP.
Viva Point: "When does VIDD begin?" Answer: Within 12 hours of initiating controlled mechanical ventilation. This is why early spontaneous breathing trials and minimising over-sedation are emphasised in modern ICU care.
Viva Point: "How does PEEP affect the kidneys?" Answer: PEEP reduces cardiac output and venous return, activates the RAAS and sympathetic nervous system, increases ADH, reduces ANP - resulting in oliguria, sodium retention, and reduced GFR. The extent depends on mean airway pressure.
-
Why does MV reduce cardiac output? PPV raises intrathoracic pressure -> compresses venae cavae -> reduces venous return -> reduces RV preload -> reduces CO (Frank-Starling). Also raises PVR, increasing RV afterload.
-
When is reduced CO from MV actually beneficial? In acute LV failure/cardiogenic pulmonary oedema - raised intrathoracic pressure unloads the LV (reduces afterload) and helps reverse the failure.
-
Define the 4 types of VILI: Barotrauma (pressure), Volutrauma (volume/overdistension), Atelectrauma (shear from cycling), Biotrauma (cytokine/inflammatory mediator release).
-
Target settings for lung-protective ventilation: Tidal volume 6 mL/kg PBW, plateau pressure ≤30 cmH₂O, titrated PEEP, permissive hypercapnia acceptable (pH >7.2).
-
When does VIDD begin? Within 12 hours. ~50% of patients lose >10% diaphragm mass in the first few days. Mechanism: disuse -> ROS -> ubiquitin-proteasome and autophagic proteolysis.
-
How does MV affect the kidneys? Via three routes: hemodynamic (↓CO -> ↓RBF), neurohumoral (RAAS, sympathetic, ADH), and direct venous congestion (↑renal venous pressure -> ↑Na reabsorption). Result: oliguria, Na retention, risk of AKI.
-
What is atelectrauma? Shear injury from repeated opening and closing of unstable alveoli with each breath - prevented by adequate PEEP above the lower inflection point of the P-V curve.
-
Define biotrauma: Release of cytokines (IL-1, IL-6, TNF-alpha) from mechanically stressed lung tissue causing systemic inflammation that can drive multi-organ failure.
-
What is VAP? How prevented? Pneumonia >48h post-intubation. Prevention: semi-recumbent positioning (30-45°), daily sedation breaks, subglottic suctioning, early weaning.
-
PPV effect on CVP/PCWP measurements: Both are artifactually elevated by positive intrathoracic pressure - must interpret with caution; end-expiratory values are most accurate.